BACKGROUND: The authors explored the relationship between nitrous oxide use and neurologic and neuropsychological outcome in a population of patients likely to experience intraoperative cerebral ischemia: those who had temporary cerebral arterial occlusion during aneurysm clipping surgery. METHODS: A post hoc analysis of a subset of the data from the Intraoperative Hypothermia for Aneurysm Surgery Trial was conducted. Only subjects who had temporary arterial occlusion during surgery were included in the analysis. Metrics of short-term and long-term (i.e., 3 months after surgery) outcome were evaluated via both univariate and multivariate logistic regression analysis. An odds ratio (OR) greater than 1.0 denotes a worse outcome in patients receiving nitrous oxide. RESULTS: The authors evaluated 441 patients, of which 199 receivednitrous oxide. Patients receiving nitrous oxide had a greater risk of delayed ischemic neurologic deficits (i.e., the clinical manifestation of vasospasm) (OR, 1.78, 95% confidence interval [CI], 1.08-2.95; P = 0.025). However, at 3 months after surgery, there was no difference in any metric of gross neurologic outcome: Glasgow Outcome Score (OR, 0.67; CI, 0.44-1.03; P = 0.065), Rankin Score (OR, 0.74; CI, 0.47-1.16; P = 0.192), National Institutes of Health Stroke Scale (OR, 1.02; CI, 0.66-1.56; P = 0.937), or Barthel Index (OR, 0.69; CI, 0.38-1.25; P = 0.22). The risk of impairment on at least one test of neuropsychological function was reduced in those who received nitrous oxide (OR, 0.56; CI, 0.36-0.89; P = 0.013). CONCLUSION: In this patient population, use of nitrous oxide was associated with an increased risk for the development of delayed ischemic neurologic deficits; however, there was no evidence of detriment to long-term gross neurologic or neuropsychological outcome.
RCT Entities:
BACKGROUND: The authors explored the relationship between nitrous oxide use and neurologic and neuropsychological outcome in a population of patients likely to experience intraoperative cerebral ischemia: those who had temporary cerebral arterial occlusion during aneurysm clipping surgery. METHODS: A post hoc analysis of a subset of the data from the Intraoperative Hypothermia for Aneurysm Surgery Trial was conducted. Only subjects who had temporary arterial occlusion during surgery were included in the analysis. Metrics of short-term and long-term (i.e., 3 months after surgery) outcome were evaluated via both univariate and multivariate logistic regression analysis. An odds ratio (OR) greater than 1.0 denotes a worse outcome in patients receiving nitrous oxide. RESULTS: The authors evaluated 441 patients, of which 199 received nitrous oxide. Patients receiving nitrous oxide had a greater risk of delayed ischemic neurologic deficits (i.e., the clinical manifestation of vasospasm) (OR, 1.78, 95% confidence interval [CI], 1.08-2.95; P = 0.025). However, at 3 months after surgery, there was no difference in any metric of gross neurologic outcome: Glasgow Outcome Score (OR, 0.67; CI, 0.44-1.03; P = 0.065), Rankin Score (OR, 0.74; CI, 0.47-1.16; P = 0.192), National Institutes of Health Stroke Scale (OR, 1.02; CI, 0.66-1.56; P = 0.937), or Barthel Index (OR, 0.69; CI, 0.38-1.25; P = 0.22). The risk of impairment on at least one test of neuropsychological function was reduced in those who received nitrous oxide (OR, 0.56; CI, 0.36-0.89; P = 0.013). CONCLUSION: In this patient population, use of nitrous oxide was associated with an increased risk for the development of delayed ischemic neurologic deficits; however, there was no evidence of detriment to long-term gross neurologic or neuropsychological outcome.
Authors: Steven W Anderson; Michael M Todd; Bradley J Hindman; William R Clarke; James C Torner; Daniel Tranel; Bongin Yoo; Julie Weeks; Kenneth W Manzel; Satwant Samra Journal: Ann Neurol Date: 2006-11 Impact factor: 10.422
Authors: Jeffrey J Pasternak; Diana G McGregor; Darrell R Schroeder; William L Lanier; Qian Shi; Bradley J Hindman; William R Clarke; James C Torner; Julie B Weeks; Michael M Todd Journal: Mayo Clin Proc Date: 2008-04 Impact factor: 7.616
Authors: Diana G McGregor; William L Lanier; Jeffrey J Pasternak; Deborah A Rusy; Kirk Hogan; Satwant Samra; Bradley Hindman; Michael M Todd; Darrell R Schroeder; Emine Ozgur Bayman; William Clarke; James Torner; Julie Weeks Journal: Anesthesiology Date: 2008-04 Impact factor: 7.892
Authors: Rupert Kett-White; Peter J Hutchinson; Pippa G Al-Rawi; Marek Czosnyka; Arun K Gupta; John D Pickard; Peter J Kirkpatrick Journal: J Neurosurg Date: 2002-06 Impact factor: 5.115
Authors: Hoang P Nguyen; Jonathan G Zaroff; Emine O Bayman; Adrian W Gelb; Michael M Todd; Bradley J Hindman Journal: Anesthesiology Date: 2010-08 Impact factor: 7.892
Authors: Guy Haller; Matthew T V Chan; Christophe Combescure; Ursula Lopez; Isabelle Pichon; Marc Licker; Roxane Fournier; Paul Myles Journal: Sci Rep Date: 2021-06-02 Impact factor: 4.379
Authors: Tumul Chowdhury; Andrea Petropolis; Marshall Wilkinson; Bernhard Schaller; Nora Sandu; Ronald B Cappellani Journal: Anesthesiol Res Pract Date: 2014-03-03